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ABSTRACT
Purpose To identify the aggregation mechanism and the stabil-
ity characteristics of three different monoclonal antibodies under
acidic conditions.
Methods The aggregation kinetics is analyzed by a combina-
tion of light scattering, size exclusion chromatography and fluo-
rescence techniques and the aggregation data are correlated to
protein structure, hydrophobicity, charge and antibody
subclass.
Results In the investigated conditions, the antibody aggregation
follows a mechanism consisting of two-steps: reversible mono-
mer oligomerization followed by irreversible cluster-cluster ag-
gregation. The kinetics of the two steps is differently affected by
the operating conditions: mild destabilizing conditions induce
formation of oligomers which are stable within weeks, while
stronger denaturing conditions promote aggregation of
oligomers to larger aggregates which eventually precipitate.
For different antibodies significant differences in both oligomer-
ization and growth rates are found, even for antibodies belong-
ing to the same subclass. For all antibodies the aggregate
formation is accompanied by a structure re-organization with
an increase in the ordered β-sheet structures. At low pH the
aggregation propensity of the investigated antibodies does not
correlate with antibody subclass, surface net charge and hydro-
phobicity of the non-native state.
Conclusions The aggregation mechanism of three antibodies
in acidic conditions as well as differences and analogies in their
stability behavior has been characterized.
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ABBREVIATIONS
ANS 8-Anilinonaphthalene-1-sulfonate
CD circular dichroism
DLS dynamic light scattering
HMW high molecular weight
Ig immunoglobulin
mAb monoclonal antibody
MRE mean residue ellipticity
MW molecular weight
SEC size exclusion chromatography
ThT thioflavin-T
INTRODUCTION
In the last years, many therapeutic proteins have been
developed versus cancer and several immunological disorders
(1,2). The successful application of this important class of
drugs requires avoiding any form of degradation. Protein
aggregation is the major form of instability occurring during
production, shipping and storage (3,4). Aggregation during
production must be avoided because it leads to loss of
valuable product, although aggregates could be removed
by chromatographic steps. Moreover, protein aggregates
formed during shipping or storage may potentially induce
immunological reactions in patients (5).
A potential source of protein aggregation is represented
by the several types of stresses (thermal, acidic, mechanical,
interaction with surfaces) which protein may face during the
various production steps: expression, purification and for-
mulation (6). In all of them proteins are exposed to changes
of operating parameters such as pH, temperature, salt con-
centration, buffer composition, shear rate and surfaces. An
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example is represented by the purification process, which is
the main part of the downstream portion of recombinant
protein production: during this step the conditions of pH
and buffer composition are changed in order to favor chro-
matographic adsorption or desorption. These parameters
may affect protein structure stability and protein-protein
interactions, inducing aggregation (7,8).
Depending on the operating conditions, several aggrega-
tion mechanisms and types of aggregates have been ob-
served (9,10). The monomeric protein can aggregate either
in the native state or in a non-native conformation and
aggregation can be either reversible or irreversible. Many
experimental studies investigated independently the effect of
one or few variables on protein unfolding and aggregation,
with large attention given to pH and ionic strength (11–14).
Buffer composition (15), particularly anions (16), affects
significantly aggregation propensity. In addition, tempera-
ture (17), protein concentration (18,19) and interactions
with surfaces (20,21) are other relevant parameters for pro-
tein aggregation behavior.
The aggregation propensity of a given protein depends
not only on the environment but also on the intrinsic pri-
mary sequence and structure of the protein. Antibodies
(mAbs) are multi-domain proteins consisting of a constant
domain (Fc) and two identical domains containing the var-
iant region (Fab). IgG is one class of immunoglobulins
exhibiting several subclasses in humans (IgG1, IgG2, IgG3
and IgG4) (22). mAbs within each subclass share the con-
stant Fc domain and differ in the variable Fab domain. In
order to correlate aggregation propensity and structure
properties, several recent works compare different IgG
subclasses (23–25). Particular attention is given in eluci-
dating the role of the single domains (Fc and Fab) in
protein self-assembling. In parallel with the experimental
approach, in silico studies try to identify aggregating-
prone regions or “hot” spots in order to optimize protein
sequence engineering against aggregation (26,27). Protein
glycosylation was also found to have a potential role in
modulating aggregation (28–30).
The large number of intrinsic and extrinsic factors in-
volved in protein stability complicates the rationalization of
the problem. On one hand, different proteins share com-
mon features in aggregation behavior and the different
observed aggregation mechanisms have been classified in a
limited number of classes (31,32). On the other hand, it is
still not possible to predict a priori the stability of a given
protein, and the optimization of formulations and process-
ing conditions requires ultimately specific studies. Investiga-
tion of the aggregation mechanism and of analogies among
different proteins under different operating conditions may
allow us reaching general conclusions about the environ-
mental or structure protein characteristics which determine
its aggregation.
In this work, we investigate the aggregation mechanism
and the stability characteristics of an IgG2 and two IgG1
proteins in acidic conditions. Low pH values are required by
purification steps commonly applied in industrial process-
ing, such as Protein A Chromatography and virus inactiva-
tion. These conditions favor the formation of aggregates
which have to be removed, thus leading to significant loss
in the process yield (8). We characterize the aggregation
kinetics in a sufficiently large range of operating conditions
by Dynamic Light Scattering (DLS), Size Exclusion Chro-
matography (SEC) and fluorescence techniques. In the first
part of the work, the stability behavior of the IgG2 protein is
described in detail, while in the second part the aggregation
data of the different antibodies are compared and correlated
to proteins structure, thermal stability, hydrophobicity and
surface charge.
MATERIALS AND METHODS
Materials
IgG2 (pI between 7.35 and 8.15), IgG1.1 (pI about 8.5), and
IgG1.2 (pI between 8.5 and 9) were stored as 45 g/L
solutions in 25 mM sodium phosphate at pH 6.0 with
100 mM NaCl at 4°C.
The solutions for aggregation studies were prepared by
manually diluting the mother solution to 1 g/L by selected
buffer solutions. For selected conditions the aggregation
experiments were repeated preparing the protein solution
with an alternative procedure: the mother solution was
extensively dialyzed in acidic buffers at 4°C before inducing
aggregation by salt addition and incubation at proper tem-
perature. The same results were obtained for the solutions
prepared according to the two methods, thus indicating that
the dilution applied in the first method is sufficient to neglect
the contribution of the buffer composition of the mother
solution on the aggregation behavior at low pH.
For each condition three repetitions were performed and
average values were considered. All buffers for aggregation
studies were filtered using 0.20 μm cut-off sterile syringe
filters Pall® Acrodisc® 32 mm (PALL Life Sciences, NY,
USA). 0.5 g/L of sodium azide was added to all solutions to
prevent formation and proliferation of bacterial growth. All
chemicals were supplied by Sigma Aldrich (Buchs, CH).
Light Scattering
Dynamic light scattering (DLS) of aggregating protein sol-
utions was measured in situ at a fixed angle of θ0173° using
a Zetasizer Nano (Malvern, UK) with laser beam of wave-
length λ00633 nm. The so-called Z-average size is obtained
by fitting the autocorrelation function with the method of
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cumulants. From the first cumulant the average particle
diffusion coefficient, D, is evaluated and the Z-average hy-
drodynamic radius, Rh, of the solution is calculated by
applying the Stokes-Einstein equation:
D ¼ kT
6pηRh
ð1Þ
Where k is the Boltzmann constant, T is the temperature
and η is the solution viscosity.Before incubation, all solutions
were filtered with a 0.02 μm cut-off, Anotop 10 syringe filter
(Whatman, Kent, UK). For selected conditions, DLS meas-
urements were repeated by filtering the solutions before
incubation with a 0.20 μm cut-off, Millex syringe filter
(Millipore, Billerica, MA, USA). The same results were
obtained for samples prepared with the two different cut-
off filters, indicating that the applied filtration before incu-
bation does not affect the aggregation kinetics.
For each investigated condition, at least three indepen-
dent samples were prepared and analyzed, and average
values are reported. This procedure applies also to the other
techniques used in this work. Evidences of the reproducibil-
ity of the data obtained with DLS as well as with the other
techniques are reported in the Supplementary Material.
Static light scattering (SLS) of fractionated samples was
measured by coupling an on-line static light scattering de-
tector (Wyatt, Dernbach, DE) to the size exclusion column.
The molecular weight of the fractionated species (MW) has
been evaluated by the Wyatt Astra software® using the
Zimm plot equation at low protein concentration:
K  c
R θð Þ ¼
1
MW  P θð Þ ð2Þ
where c is the protein concentration, R is the excess Rayleigh
scattering ratio at the angle θ, P is the form factor and K is
an optical constant defined as K ¼ 4p2 dn dc=ð Þ2n2N 1A l40 ,
where n is the refractive index of the solvent, dn/dc is the
refractive index increment, NA is the Avogadro number and
λ0 is the wavelength of the incident light. For dn/dc the value
of 0.185 mL/g, typical for protein aqueous solutions, has
been assumed.
Size Exclusion Chromatography (SEC)
Size exclusion chromatography (SEC) was performed with a
Superdex 200 10/300 GL, 10 mm×300 mm size-exclusion
column (GE Healthcare, Uppsala, SE) mounted on a Agi-
lent 1100 series HPLC unit (Santa Clara, CA, USA) con-
sisting of a quaternary pump with degasser, an autosampler,
a column oven, and a UV detector. Protein solutions for
SEC analysis were incubated in glass vials at appropriate
temperatures. At selected time points along the aggregation
process aliquots of 30 μL taken directly from the vials were
injected into the SEC column by an automatic injector and
eluted for 60 min at a constant flow rate of 0.5 mL/min
using as mobile phase a solution of 100 mM sodium sulfate
and 25 mM Na2HPO4 at pH 7.0. The UV absorbance
chromatograms were detected at 280 nm. Samples were
not centrifuged before the injection. Residual monomer
amount was evaluated by calculating the area under the
monomer peak in the non-normalized SEC chromatograms
with the Agilent ChemStation software (Santa Clara, CA,
USA). When the baseline between the peaks of monomer
and dimer was not resolved, the monomer peak was
defined by dropping a perpendicular in the valley be-
tween the monomer and the dimer peak at a fixed elution
time.
Thioflavin-T (ThT) and 8-Anilinonaphthalene-1-sulfonate
(ANS) binding
ThT and ANS fluorescence were measured using an EnS-
pire 2300 Multilabel Plate Reader (Perkin Elmer, Waltham,
MA, USA) with a standard 96 wells black plate with a
transparent bottom (ProxiPlate-96, Perkin Helmer, USA).
25 μM ThT or ANS were added to 1 g/L protein solutions,
corresponding to a dye-to-protein molar ratio of 3.7. ThT
emission at 485 nm was recorded after excitation at a
wavelength of 450 nm, while ANS emission at 490 nm
was recorded after excitation at a wavelength of 403 nm.
To avoid heterogeneity in the measurements, fluores-
cence values were averaged over 9 different points inside
each well (grid 3×3). Three repetitions were performed
for each sample. To investigate the hydrophobicity of
the monomeric proteins before aggregation, ANS spectra
of 0.3 g/L protein solutions in proper buffers were
acquired by recording ANS emission from 420 to
600 nm.
Circular dichroism (CD)
Circular dichroism (CD) spectra of 0.3 g/L protein solutions
in proper buffers were acquired on a Jasco-815 CD spec-
trophotometer (Jasco, Easton, MD, USA). Far-UV CD
spectra were recorded from 260 to 190 nm with the tem-
perature of the cell holder controlled at 20°C. A quartz
cuvette with 0.1 cm path length was used. Spectra obtained
after buffer subtraction were corrected for protein concen-
tration, smoothed using the Savitsky-Golay function and
normalized with respect to the number of aminoacids to
obtain mean residue ellipticities (MRE).
Thermal stability of 0.3 g/L protein solutions in 25 mM
citric acid buffer at pH 3.0 without salt was evaluated by
recording the spectra at several temperatures heating from
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15°C to 90°C with a step of 1°C. The protein unfolding was
monitored at 210 nm.
Zeta Potential
Zeta potential values of proteins (z) have been evaluated by
a Zetasizer Nano (Malvern, Worcestershire, UK) measuring
the electrophoretic mobility (μ) via laser Doppler effect.
From the electrophoretic mobility, μ, the zeta potential, z,
is calculated according to Henry equation:
μ ¼ 2  "  z
3  η ð3Þ
where ε and η are the dielectric constant and the viscosity of
the medium, respectively.
0.3 g/L protein solutions in 25 mM citric acid buffer in
the pH range from 3.0 to 6.0 and in 25 mM phosphate
buffer in the pH range from 7.0 to 9.0 have been measured
at 25°C. Five repetitions of three independent samples were
recorded for each condition and average values have been
considered.
RESULTS
Effect of operating conditions on IgG2 stability
The stability of the IgG2 antibody at room temperature
was described in a previous work (7): the protein is
stable above a critical pH value of 4.5 for several days,
while for lower pH values the antibody reversibly aggre-
gates to dimers and trimers within few hours (7). Here
we investigate the aggregation behavior in the temper-
ature range from 4°C to 37°C and pH range from 3.0
to 4.5 in the presence and in the absence of different
salts (25 mM citric acid buffer with and without
150 mM NaCl or Na2SO4). A similar qualitative behav-
ior was observed in the presence of NaCl and Na2SO4,
with faster aggregation occurring in the presence of
Na2SO4. For sake of simplicity we report in the follow-
ing only the results obtained in the presence of sodium
sulfate. Results and discussion on the effect of the salt
are reported in the Supplementary Material. The ag-
gregation kinetics is followed in situ by dynamic light
scattering (DLS) and samples taken at different incuba-
tion times are analyzed by size exclusion chromatogra-
phy (SEC). To describe the aggregation state of the
IgG2 under different conditions, we show in Fig. 1 the
normalized size exclusion chromatograms of 1 g/L pro-
tein solutions after a characteristic incubation time of
6 h in 25 mM citric acid buffer with 0.15 M Na2SO4
for several pH and temperature values. The peak at
about 25 min elution time corresponds to monomeric
antibody, while the peaks at shorter elution times rep-
resent aggregates. Aggregates larger than about six mo-
nomeric units are excluded from the column volume
and elute all simultaneously in the void peak at
18 min (Fig. 1i). At the considered salt concentration,
three types of behavior can be identified in the pH-
temperature plane investigated in Fig. 1 after 6 h of
incubation time: 1) stable solutions (Fig. 1a, b, d) which
exhibit the same SEC chromatogram of the non-stressed
sample; 2) formation of soluble oligomers (Fig. 1c, e, f,
g, h), and 3) formation of submicron aggregates, which
will be defined in the following as high molecular
weight (HMW) aggregates (Fig. 1i). Aggregation is pro-
moted either by decreasing pH or by increasing tem-
perature. In particular, by increasing temperature from
4°C to 25°C and from 25°C to 37°C the critical pH
value for oligomer formation shifts from 3.0 to 4.0 and
from 4.0 to 4.5, respectively. Moreover, at pH 3.0 and
37°C the formed oligomers are not stable and grow to
larger aggregates within hours, while in the conditions
of Fig. 1c, e, f, g, h the formed oligomers are rather
stable within weeks. It is worth noticing that in this
work we refer to the kinetic stability of the protein
solutions. Therefore, we specify the time scale
corresponding to the observed stability/aggregation of
a given solution. Oligomers solutions which are thermo-
dynamically unstable and aggregate within weeks can be
considered rather stable from a kinetic point of view
within hours of incubation.
At pH 3.0 and 37°C (conditions of Fig. 1i) mass lost is
observed during the SEC analysis of samples taken after 3 h
of incubation, indicating formation of large aggregates. On
the other hand, full mass recovery is obtained for all the
soluble oligomer distributions measured under the condi-
tions of Fig. 1c, e, f, g, h, for which the area under the
chromatograms is constant during time. For these samples,
the molecular weight (MW) of the soluble oligomers has
been measured by static light scattering. The measurements
indicate the presence of mainly dimer and trimer, as shown
for a representative SEC chromatogram with the
corresponding MW in the Supplementary Material. In the
following, the soluble oligomers will be treated as a single
lumped species corresponding to all the oligomers eluting
between 16 and 24 min in the SEC chromatograms,
without distinguishing between dimers, trimers and larger
oligomers.
It is well known that the off-line SEC analysis suffers from
limitations due to interactions between the aggregates and
the stationary phase of the column or possible formation of
monomer from reversible aggregates upon dilution with the
mobile phase (33). Such non-ideal effects are strongly affect-
ed by the buffer composition of the mobile phase (34). It is
therefore important to check the reliability of the SEC
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chromatograms by performing comparison with orthogonal
techniques (33). For the soluble oligomer chromatograms,
where full mass recovery is observed, the reliability of the
SEC chromatograms has been verified by coupling an on-
line DLS detector (Wyatt, Dernbach, DE) with the SEC
column, so as to estimate the average hydrodynamic radius
of the oligomer distribution determined from the SEC tech-
nique. This value was found to be reasonably in agreement
with the hydrodynamic radius of the non-fractionated sam-
ple evaluated in situ by DLS, therefore indicating that the
SEC chromatograms of the soluble oligomers can be con-
sidered reliable (7). Moreover, measurements of selected
samples were repeated using a TSK gel G3000SWxl col-
umn (Tosoh Bioscience LLC, Montgomeryville, PA) with
100 mM sodium sulfate and 25 mM Na2HPO4 at pH 6.0 as
mobile phase. The results obtained with the G3000SWxl
column and mobile phase at pH 6.0 were rather similar to
the results obtained with the Superdex 200 column and
mobile phase at pH 7.0, thus confirming the reliability of
the results.
The oligomers observed in Fig. 1 can be either interme-
diate species in the system evolution to the larger aggregates
or the product of an alternative aggregation mechanism. In
order to better investigate these two cases, we followed the
oligomer stability for longer times and in different
conditions.
In Figure 2a the three situations which appeared less
stable for the incubation time of 6 h (Fig. 1i, f, h) are now
monitored for 15 h at the corresponding temperature in
Fig. 1 by showing the Z-average hydrodynamic radius,
Fig. 1 Normalized SEC chromatograms of 1 g/L protein solution after 6 h of incubation in 25 mM citric acid buffer with 0.15 M Na2SO4 at several pH and
temperature values
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<Rh>, measured by DLS as a function of time. It is seen that
the oligomers in Fig. 1i are not stable and undergo massive
aggregation after about 12 h, while the other two remains
substantially stable in the 15 h. The DLS intensity signal for
the oligomers in Fig. 1i increases in the first 12 h due to
aggregation, and later decreases, indicating precipitation of
the aggregates. At the end of the aggregation process the
aggregates are visually insoluble, and precipitate on the
bottom of the cuvette (data reported in the Supplementary
Material).
It is worth noticing that the DLS analysis applied in this
work provides only an average value of the aggregate dis-
tribution without giving reliable information about the
shape of the distribution. Moreover this technique cannot
detect properly the aggregation kinetics of large size
aggregates, when aggregates precipitation occurs. In this
work we detect the initial aggregation of monomer and
oligomers by monitoring changes of the average hydro-
dynamic radii in the size range from few to 150 nm,
corresponding to non-sedimentating conditions. We do
not address aggregation kinetics of larger aggregates and
change of size distribution, for which other techniques
such as field-flow fractionation and microscopy techni-
ques are required (35).
By prolonging the experiment duration to 45 days we
see that also oligomers in Fig. 1h, f aggregate but in a
longer time scale involving tens of days. Oligomers in
Fig. 1h undergo massive aggregation after about 30 days,
while precipitation of micron aggregates formed by the
oligomers in Fig. 1f was observed after more than two
months.
It is worth noting that the profile of the time evolution of
the average size is similar in all the investigated conditions,
as seen by comparing the slower kinetics in Fig. 2b to the
faster kinetics at 37°C and pH 3.0 in Fig. 2a. A slow, almost
linear increase of the average size during the initial times is
followed by a fast acceleration leading to the formation of
insoluble aggregates in the micron range which, eventually,
precipitate.
From the data shown in Fig. 2 we can conclude that the
oligomers observed in Fig. 1 are intermediates in the aggre-
gation process leading to larger micron precipitates. The
kinetics of oligomer-oligomer aggregation and, therefore,
the oligomers life-span depend on the operating conditions,
and particularly on pH and temperature, i.e., on the dena-
turing conditions.
These results evidence the multi-variable nature of this
stability problem, which involves a combined effect of salt,
pH and temperature on the aggregation kinetics. The latter
is most likely related to unfolding of the native structure,
induced with different combinations of operating parame-
ters. On the other hand, the aggregation mechanism seems
to be the same in all conditions as discussed in the next
section.
IgG2 Aggregation Mechanism
The mechanism of aggregation was investigated in more
detail for the following reference conditions: 1 g/L protein
solution in 25 mM citric acid buffer with 0.15 M Na2SO4
and 37°C. In Fig. 3 the first 3 h of the time evolution of the
normalized SEC chromatograms and of the corresponding
average molecular weight of the soluble oligomers in the
reference condition and different pH values are compared.
In particular, we consider in the sequel three pH values:
3.0, 4.0 and 4.5, which correspond to the operating
conditions i, f and c in Fig. 1, and therefore are referred
to 1i, 1 f and 1c in the sequel, respectively. It is seen
that the time evolution of the chromatograms at pH 4.5
(Fig. 3a) and pH 4.0 (Fig. 3b) is similar, with a kinetics
slightly faster at pH 4.0. On the other hand, at pH 3.0
already after 1 h species larger than trimer are observed
(Fig. 3c and d).
From the non-normalized chromatograms the residual
monomer amount has been evaluated by the ratio between
Fig. 2 Time evolution of the Z-average hydrodynamic radius, <Rh>,
measured by dynamic light scattering for a 1 g/L protein solution in 25 mM
citric acid buffer with 0.15 M Na2SO4. (a) at 37°C and pH 3.0 (1I) (○), at
25°C and pH 3.0 (1 H) (▲), and at 37°C and pH 4.0 (1 F) (□); (b) at 25°C
and pH 3.0 (1 H) (▲), and at 37°C and pH 4.0 (1 F) (□).
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the area under the monomer peak and the area of the
control monomeric sample. In Fig. 4a the time evolution
of the residual monomer amount at the different pH values
is compared. Despite the difference in molecular weight,
after 3 h of incubation the residual monomer at all pH
values is comparable, being 11.9±0.4% at pH 3.0, 23.4±
2.6% at pH 4.0 and 24±2.9% at 4.5.
The difference in aggregate size at the different pH
values increases further at 6 h of incubation. The
corresponding SEC chromatograms are shown in Fig. 1
(i.e., 1c, 1 f and 1i), while the DLS data are shown in
Fig. 2a, indicating an average radius, <Rh>, of 30±1 nm
at pH 3.0 and of 10±1 nm at pH 4.0. Despite such a
difference in size, the difference in residual monomer be-
tween the two pH values is only of about 10%, being the
residual monomer equal to 6.3±2% at pH 3.0 and 17±
1.5% at pH 4.0 (Fig. 3d).
At longer times (about 10–12 h), for the case pH03.0 (Fig. 2a)
a strong acceleration in aggregation is observed through the
strong increase of the Z-average hydrodynamic radius measured
by DLS. Since this occurs when the monomer consumption is
almost complete, as shown in Fig. 4b, we can conclude that most
likely the formation of HMW aggregates is not due to monomer
addition but to cluster-cluster aggregation.
Fig. 3 Time evolution of
normalized size exclusion
chromatograms of 1 g/L protein
solution in 25 mM citric acid
buffer with 0.15 M Na2SO4 at
37°C and several pH values: (a)
pH 4.5 (1c); (b) pH 4.0 (1 f); (c)
pH 3.0 (1i); (d) Time evolution of
the average molecular weight of
the soluble oligomers eluting be-
tween 16 and 24 min in the
chromatograms in (a), (b) and (c)
normalized with respect to the
molecular weight of the mono-
mer (MW0). When not visible,
error bars are smaller than the
symbols. (*) for the sample at pH
3.0 (1i) after 3 h of incubation
time, 15.6±7% of mass lost is
observed during SEC analysis. At
pH 4.0 and 4.5 only dimers and
trimers are visible, while at pH
3.0 aggregation proceeds to
larger aggregates.
Fig. 4 (a) Residual monomer fraction versus time evaluated from the non-normalized SEC chromatograms of Fig. 3; (b) time evolution of the residual
monomer fraction (▲) (right axis) and of the average hydrodynamic radius (○) (left axis) at pH 3.0 (1I).
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We investigated the reversibility of the aggregates formed
during the aggregation (i.e., the possibility to dissociate the
aggregates into monomers by reverting to the original solu-
tion conditions) (10) by taking two samples after a selected
time of incubation: one sample was immediately analyzed
by SEC, while the second one was diluted twenty-folds in
25 mM citric acid buffer at pH 3.0 without salt, and ana-
lyzed after 3 h. As shown in Fig. 5, the dilution of samples
taken in the very early stages (after 5 min of incubation)
leads to a significant monomer recover from oligomers. This
clearly indicates that the initial oligomerization step at 37°C
is reversible, as observed earlier for the same oligomeriza-
tion process at room temperature (7). On the other hand,
the dilution of samples taken after 10 h of incubation does
not lead to a decrease in the aggregate average size or to
monomer formation, indicating that the formed aggregates
are mostly irreversible.
From the experimental evidences collected so far we can
envision the pH-induced aggregation process as a two-step
process. In the first one, monomeric antibodies form soluble
oligomers consisting mainly of dimers-trimers. Dilution of
the oligomer mixture in a salt-free solution leads to mono-
mer recover from the oligomers, indicating that this first step
can be considered reversible. In the second step, an auto-
accelerating cluster-cluster aggregation takes place. The
transition between the two steps, and therefore the
oligomers life-span, can occur at different times and it is
indeed accelerated at pH 3.0 with respect to pH 4.0 and 4.5.
Changes in protein secondary structure during aggrega-
tion were assessed by Thioflavin-T (ThT) and 8-
Anilinonaphthalene-1-sulfonate (ANS) binding studies (36),
which give information about the β-sheet content (37) and
the hydrophobicity of the protein (38), respectively. In
Figure 6a the ThT fluorescence values versus time are shown
for the three pH values investigated, corresponding to con-
ditions 1 f, 1c and 1i. It is seen that the fluorescence signal
increases with an extent proportional to aggregation, indi-
cating that the latter is accompanied by β-sheet formation:
at pH 3.0 a continuous increase of fluorescence is observed,
while at pH 4.0 and 4.5 only an initial increase related to
oligomer formation is detected. A similar behavior was
observed for ANS binding.
In Figure 6b the correlation between aggregation and
structure changes is evidenced for the more unstable condi-
tion, 1I, by plotting the ThT fluorescence values and<Rh>
versus monomer conversion: both quantities increase non-
linearly with respect to monomer conversion and follow a
similar profile, thus proving the strong correlation between
Fig. 6 (a) ThT fluorescence values for 1 g/L protein solution in 25 mM
citric acid buffer with 0.15 M Na2SO4 at 37°C at pH 3.0 (1i) (□), pH
4.0 (1 f) (■) and pH 4.5 (1c) (○); (b) ThT fluorescence values (△)
and Z-average hydrodynamic radius (●) versus monomer conversion
for the reference reaction at pH 3.0 (1i); (c) ThT (○) and ANS (■)
fluorescence values versus Z-average hydrodynamic radius for the
reference reaction at pH 3.0 (1i).
Fig. 5 Mass percentage of oligomers (black bars) and monomers (grey
bars) determined from the SEC technique for (a) a 10 g/L mAb sample
taken after 5 min incubation in 25 mM citric acid buffer at pH 3.0 and 37°C;
(b) the same sample as (a) diluted 20 folds in 25 mM citric acid buffer at pH
3.0 without salt and incubated for 3 h at 25°C.
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the two quantities. This is confirmed by plotting ThT and
ANS values versus<Rh>, as reported in Fig. 6c: the fluores-
cence values grow rapidly with the average size indicating
the structure re-arrangement of the formed oligomers. With
increasing average size, the change in fluorescence values
reduces until reaching a plateau: this corresponds to the fast
acceleration in aggregation kinetics observed in Fig. 2a.
During this step, the aggregates grow too fast to allow
internal re-arrangements.
Re-organization of microdomains inside the clusters and
formation of distorted intermolecular β-sheet during aggre-
gation have already been observed for the antibody under
investigation (7) as well as for others (12,14,39). However,
the features of such re-structuring are still unclear. We
compared the increase of ThT fluorescence during mAb
aggregation observed above with the increase found during
aggregation of an equivalent amount of insulin in similar
conditions of pH and ionic strength. Under such conditions
insulin forms fibrillar aggregates with a large amount of
amyloid β-sheet structures. After 15 h incubation, in the
case of insulin the ThT fluorescence value increases from
470±50 a.u. to 470000±4000 a.u, while in the case of mAb
its value increases from 1400±500 a.u. to 9400±400 a.u.
The value of ThT fluorescence of mAb aggregates is there-
fore about 2% of the value for insulin fibrils, indicating that
the β-sheet formation in antibody aggregates is quite limited
with respect to the extremely regular architecture of amy-
loid fibrils.
Based on the experimental evidences collected so far we
can propose the aggregation mechanism schematically
depicted in Fig. 7. The aggregation is initiated by a revers-
ible oligomerization involving mainly monomers, dimers
and trimers. In suitable conditions, for example of pH and
temperature, such oligomers are not stable and grow via
irreversible cluster-cluster aggregation within hours. The
formed large aggregates become progressively less soluble
and, eventually, precipitate. In all the investigated condi-
tions the aggregation follows a unique mechanism whose
kinetics depends on the operating condition. The
aggregation is associated to a change of secondary structure
inside the cluster, as detected by ThT and ANS binding.
Correlation Between Aggregation Stability and IgG
Properties
The previous analysis was extended to other two model
immunoglobulins belonging to the IgG1 subclass, referred
to in the following as IgG1.1 and IgG1.2. The stability of
the three antibodies is compared in Table I, where the
stability character observed by SEC and DLS after a char-
acteristic time of 6 h at different pH values and temper-
atures is reported. It can be seen how the aggregation
propensity is different for the different antibodies. At pH
4.5 IgG2 is more unstable than the two IgG1s, while at
lower pH the situation is more complex: at pH 4.0 and 37°
C, IgG1.1 is stable, while IgG1.2 and IgG2 form unstable
oligomers which aggregate during time. Precipitation is
observed after some weeks for IgG1.2 and after months for
IgG2. At pH 3.0 and 25°C, IgG1.2 is the less stable and
significant precipitation is observed within 6 h of incubation.
Finally, at pH 3.0 and 37°C all antibodies precipitate within
hours.
The aggregation kinetics at 37°C and pH 3.0 was fol-
lowed by DLS, ThT and ANS binding, and monomer
conversion was measured by SEC. The DLS data in
Fig. 8a show that the aggregation kinetics in the first 3 h
follows the order: IgG1.2>IgG2>IgG1.1. It is worth notic-
ing the different behavior between IgG2 and IgG1.1: the
latter is characterized by an oligomerization step similar to
IgG2, but significantly slower, as indicated by the smaller
size of the aggregates in this period of time in Fig. 8a and the
lower monomer conversion values in Fig. 8b. Once a critical
concentration of IgG1.1 oligomers has been reached (at
about 5 h), aggregation to larger aggregates occurs with a
much faster kinetics with respect to IgG2 (Fig. 8a). On the
other hand, IgG1.2 shows in Fig. 8a to exhibit the fastest
aggregation kinetics and the fastest oligomerization rate.
Fig. 7 Scheme of the developed
aggregation mechanism for the
antibody under investigation.
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By looking at the ThT values in Fig. 8c, it appears that
the three antibodies exhibit different initial values, indicat-
ing a different structure of the non-native monomers. In
particular we see that the aggregation of all antibodies is
accompanied by structure changes, particularly during olig-
omer formation, and the fluorescence values of the final
aggregates correlate with that of the initial monomers and
not with aggregation rate. The slower IgG1.1 oligomer
formation is in fact accompanied by a larger increase of
order β-sheet structure with respect to the faster aggregating
IgG2. On the other hand, IgG1.2 shows the lowest ThT
binding, although its aggregation kinetics is the fastest of the
three antibodies. Possibly, because of the fast aggregation
kinetics, the internal domains do not have time to re-
organize.
In order to elucidate which property of the antibody is
crucial for the aggregation propensity at low pH, the mo-
nomeric antibodies before aggregation were characterized
in terms of thermal stability, secondary structure, hydropho-
bicity and surface charge. On this purpose, experiments
were performed in the absence of salt and at low protein
concentration (0.3 g/L) to avoid aggregation. This concen-
tration is different from the concentration considered for the
aggregation studies (1 g/L). However, the results of all the
applied techniques are based on the relative comparison of
the three antibodies and are therefore independent of the
protein concentration.
The thermal stability at pH 3.0 was investigated by
circular dichroism (CD) in absence of salt and at low protein
concentration to reduce aggregation during the measure-
ments. In Figure 9a the normalized CD mean residue ellip-
ticity (MRE) at 210 nm as a function of temperature is
reported for the different antibodies. Given the multi-
domain nature of the protein, a two-state unfolding model
would likely not apply for the considered antibodies (40). A
simple sigmoidal function was used to fit the data. The
thermal stability follows the order: IgG1.1 (most stable)>
IgG2>IgG1.2 (less stable), which is the same order observed
for the aggregation stability in the first 3 h of incubation at
pH 3.0 (Fig. 8a).
The far-UV CD spectra at 20°C and pH 3.0 without
salt are shown in Fig. 9b: the three antibodies show
different secondary structures, although all the spectra
have a minimum at about 216 nm, characteristic of the
large β-sheet content of immunoglobulins. In the IgG1.1
spectrum the minimum is shifted from 216 to 218 nm,
but the β-sheet content is comparable to IgG2. The
IgG1.2, characterized by a large propensity to aggre-
gate, has a significant lower secondary structure amount
compared to the other IgGs, in agreement with the low
ThT binding reported in Fig. 8c.
Fig. 8 Time evolution of the Z-average hydrodynamic radius, <Rh>, (a),
and of residual monomer (b) for a 1 g/L protein solution in 25 mM citric
acid buffer with 0.15 M Na2SO4 at 37°C and pH 3.0; (c) ThT fluorescence
values versus Z-average hydrodynamic radius, <Rh>, at the same con-
ditions as a): IgG2 (○), IgG1.1 (■) and IgG1.2 (△). Continuous lines are a
guide to the eyes.
Table I Type of Aggregates Observed by DLS and SEC for a 1 g/L Solution
of the Three Different IgGs after 6 h of Incubation in 25 mM Citric Acid Buffer
with 0.15 M Na2SO4 at Several pH and Temperature Values
pH T (°C) IgG2 IgG1.1 IgG1.2
4.5 37 Soluble oligomers Stable Stable
4.0 37 Soluble oligomers Stable Soluble oligomers
3.0 25 Soluble oligomers Stable Micron, insoluble
aggregates
3.0 37 Submicron aggregates Submicron
aggregates
Micron, insoluble
aggregates
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The global hydrophobicity of the three antibodies was
assessed by ANS measurements (38). The spectra were
recorded at 20°C for 0.3 g/L protein solutions in 25 mM
citric acid buffer with 25 μM ANS. In Figure 10a the
maximum fluorescence values of the ANS emission spectra
for the three antibodies solutions at different pH values are
compared. According to ANS analysis at all pH values the
protein hydrophobicity follows the order: IgG2>IgG1.1>
IgG1.2. The IgG1.2 is the less hydrophobic, despite the
largest reactivity at pH 3.0. In addition, at pH 4.0 IgG1.1
is more hydrophobic and more stable than IgG1.2. The
ANS fluorescence values increase by decreasing the pH
value, confirming denaturation and exposure of hydropho-
bic patches at lower pH.
Finally, the zeta potential values of the three antibodies
were measured as a function of pH (Fig. 10b): at pH 3.0 the
zeta potential follows the order IgG1.1>IgG2>IgG1.2,
which is in agreement with the ranking of aggregation
propensity in the first three hours (Fig. 8a). On the other
hand, at pH 4.0 IgG1.1 has the lowest zeta potential, and
therefore the lowest surface charge, although it is the most
stable of the three antibodies. Moreover, at pH 4.5 the zeta
potential of IgG1.1 and IgG2 is similar, despite their differ-
ent aggregation tendency.
DISCUSSION
For all the three considered antibodies the aggregation
propensity increases with decreasing pH at a fixed temper-
ature or with increasing temperature at a fixed pH. In both
cases, the change of conditions (pH or temperature) pro-
motes unfolding of the native protein. The formation of
soluble oligomers within the first hours of incubation at
low pH is consistent with the behavior observed with other
IgG1s at pH 3.5 (12,14). In this work, addition of salt
induces aggregation of the soluble oligomers to larger aggre-
gates at pH 3.0, while at pH 4.0 and 4.5 in the temperature
range from 25 to 37°C the soluble oligomers are stable for
several days, in contrast with the formation of HMW aggre-
gates observed with other IgG1s at pH 4.5 and larger
temperatures (12,14).
At pH 3.0 the order in thermal stability (Fig. 9a) corre-
lates with the order in aggregation stability in the first 3 h
(Fig. 8a), confirming the important role of structure stability
Fig. 9 (a) Thermal stability of the three investigated antibodies: normal-
ized CD mean residue ellipticity (MRE) at 210 nm versus temperature for a
0.3 g/L protein solution in 25 mM citric acid buffer at pH 3.0: IgG2 (○),
IgG1.1 (□) and IgG1.2 (△). Lines represent sigmoidal fitting to experimen-
tal data. (b) Far-UV CD spectra at 20°C for 0.3 g/L solutions of the three
investigated antibodies in 25 mM citric acid buffer at pH 3.0: IgG2 (―),
IgG1.1 (− −) and IgG1.2 (― •).
Fig. 10 (a) ANS fluorescence emission values at 485 nm for 0.3 g/L
solutions of IgG2 (green bars), IgG1.1 (red bars) and IgG1.2 (blue bars) at
20°C in 25 mM citric acid buffer with 25 μM ANS at different pH values.
(b) Zeta potential values as a function of pH for 0.3 g/L solutions of the
three investigated antibodies in 25 mM citric acid buffer in the pH range
from pH 3.0 to 4.5 and in 25 mM phosphate buffer in the pH range from
6.0 to 9.5: IgG2 (○), IgG1.1 (□) and IgG1.2 (△).
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in determining aggregation propensity in acidic conditions.
In general, antibody thermal stability is significantly reduced
at low pH, particularly due to the sensitivity of the CH2
domain in the Fc fragment to acidic conditions (16,24,40).
IgG2 antibodies are more prone to aggregate than IgG1
antibodies in destabilizing conditions, i.e. physiological pH
and elevated temperature (39), or acidic conditions at room
temperature (24). This behavior is generally related to the
larger stability of the CH2 domain in IgG1 antibodies with
respect to IgG2 antibodies (24,30). However, a general
conclusion on IgG subclasses cannot be achieved. In this
work, the investigated IgG2 is in fact more unstable than the
considered IgG1s at pH 4.5, while IgG1.2 (but not IgG1.1)
is more unstable than IgG2 in the pH range from 3.0 to 4.0.
These results would indicate that also the Fab fragments
contribute to the structure and aggregation stability, in
agreement with previous studies reported in the literature
(12,14,41).
The analysis of the two-step aggregation mechanism
gives information about the relationship between the stabil-
ity of non-native monomers and the stability of aggregates.
On one hand, interactions between non-native monomers
should reflect interactions between non-native aggregates.
On the other hand, aggregation could reduce the number of
hydrophobic patches exposed during unfolding, and aggre-
gates could therefore interact more similarly to native pro-
teins. In this work, exposure of the model IgG2 to mildly
destabilizing conditions was sufficient to promote reversible-
oligomerization: we believe that during the self-assembling
the available hydrophobic patches are covered, and
oligomers are rather stable within weeks. When exposed to
stronger destabilizing conditions (pH 3.0 and larger temper-
ature), the level of unfolding of the monomeric protein
increases, exposing a larger number of hydrophobic
patches. We think that under these conditions the oligomer-
ization is not enough to cover the aggregating-prone
patches, and in the presence of salt the formed oligomers
aggregate to larger ones and eventually precipitate. We
conclude that, for the IgG2 under investigation, the extent
of monomer unfolding is reflected in the stability of the
formed aggregates.
On the other hand, the non-native IgG1.1 monomer has
a lower tendency to aggregate with respect to IgG2, likely
due to the lower unfolding extent. However, the formed
oligomers aggregate much faster than the IgG2 aggregates.
This behavior could be explained considering the larger
ordered structure of IgG1.1 oligomers, as indicate by ThT
binding in Fig. 8c: possibly, during the slow oligomerization
step oligomers have more time to re-arrange in a more
organized structure, which is more prone to aggregate.
However, IgG1.2 shows the largest aggregation rates
(Fig. 8a) and the lowest amount of ordered secondary struc-
ture (Figs. 8c and 9b).
In the case of amyloidogenic proteins, i.e., a class of proteins
self-assembling in regular fibrillar structures known as
amyloids, the aggregation propensity was found to correlate
with general physicochemical properties of the proteins,
namely hydrophobicity, surface charge and amount of
ordered structure (42). For the three antibodies investigated
in this work, the change in zeta potential and in hydrophobic-
ity due to different protein structure or different pH does not
correlate with the antibody aggregation propensity. The
results suggest that for multi-domain proteins such as anti-
bodies it is difficult to associate the monomer and oligomer
reactivity to generic protein physicochemical properties, such
as hydrophobicity or charges. Aggregation kinetics in acidic
conditions appears therefore related to specific features of the
non-native monomer and oligomers, which are still unclear.
Aggregation may occur in specific binding sites, as recently
shown for antibody dimer formation at low pH (6).
It is worth noticing that the oligomerization and the
structure changes occurring in the early stages of aggrega-
tion are the less understood steps also in the kinetics of
amyloid fibril formation (43). Investigation of IgG aggrega-
tion could therefore give mechanistic insights also in the
aggregation of amyloidogenic proteins.
CONCLUSIONS
We investigate the stability of an IgG2 and two IgG1s at
acidic pH.
Two distinct steps are identified for the IgG2 aggrega-
tion: 1) reversible oligomerization involving mainly mono-
mers, dimers and trimers, and 2) irreversible cluster-cluster
aggregation leading to larger aggregates in the micron
range, which, eventually, precipitate.
Temperature, pH and salt concentration determine both
oligomerization and growth rate by affecting the protein
conformational state. In particular, mild destabilizing con-
ditions promote formation of stable oligomers; on the other
hand, stronger denaturing conditions induce oligomer-
oligomer aggregation.
In analogy with IgG2, the stability of the two IgG1s
decreases with increasing denaturing conditions, i.e. lower-
ing pH and increasing temperature. However, significantly
different aggregation rates are observed for the three anti-
bodies in different operating conditions. In particular, the
two IgG1s show lower oligomerization rate, but faster
cluster-cluster aggregation rate with respect to IgG2. More-
over, IgG2 forms oligomers with long life-spans in a broad
range of operative conditions. For all the three antibodies,
the oligomerization step is accompanied by conformational
changes with an increase in the ordered, β-sheet structures.
The aggregation propensity of the investigated antibodies
in acidic conditions does not correlate with antibody
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subclass, surface net charge and hydrophobicity of the non-
native state. The results indicate that the aggregation ten-
dency is dictated by specific features of the non-native
structure, which are still to a good extent unclear.
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